Redmile Group LLC 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 1,942,555 4.600% |
-206,193 (-9.60%) |
Filing |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,148,748 5.100% |
-535,648 (-19.95%) |
Filing |
| 2023-02-14 4:29 pm Sale |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,684,396 6.400% |
-105,100 (-3.77%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,789,496 6.700% |
141,800 (+5.36%) |
Filing |
| 2021-02-16 4:27 pm Purchase |
2020-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,647,696 7.200% |
2,647,696 (New Position) |
Filing |